NewPlastic is produced with state-of-the-art technology according to ANVISA (Brazilian Sanitary Surveillance Agency) legislation and assured by a Quality Management System implemented at Laboratório Lebon, which is responsible for its high standards of purity, control, efficiency, reliability and stability.
Lebon Produtos Químicos e Farmacêuticos Ltda.
AFE (Company Open Permit at Ministry of Health) nº 77M449LL2W4W (8.02565.1) – Diário Oficial da União (Federal Register) nº 146 - Aug. 1, 2005 - Page 59.
Click here to check the official register.
BSI (British Standards Institution) Certificate.
Cert.nº FM530581
Click here to check official document.
Microspheres
Newplastic consists of solid polymethilmetacrilate microspheres of smooth surface suspended in hydrogel. Looking for quality excellence in raw materials, a selection and purification process of the PMMA microspheres was developed so that they have a standard medium size of 45μ. The size of the microspheres avoids phagocytosis, for particles smaller than 30µ can be phagocyted by macrophages.
The proportion among microspheres ranges from 2%, 10%, and 30%.
NewPlastic comes in 1ml and 3ml syringes, and thanks to its stability, it can be stored at room temperature between 15ºC and 30ºC.
BEFORE particle
selection process
Particles already selected
Rastreabilidade:
NewPlastic is accompanied by individual labels with lot number and validity date to be attached to patient’s documentation. These data ensure one is using a product with quality, source, manufacturing records and lot tracking system.